This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1985 Oct;9(5):714-8.

doi: 10.1007/BF01655185.

A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study

W C Wood, R B Weiss, D C Tormey, J F Holland, P H Henry, L A Leone, S Rafla, R T Silver, R W Carey, G J Lesnick, et al.

PMID: 3840627
DOI: 10.1007/BF01655185

Clinical Trial

A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study

W C Wood et al. World J Surg. 1985 Oct.

. 1985 Oct;9(5):714-8.

doi: 10.1007/BF01655185.

Authors

W C Wood, R B Weiss, D C Tormey, J F Holland, P H Henry, L A Leone, S Rafla, R T Silver, R W Carey, G J Lesnick, et al.

PMID: 3840627
DOI: 10.1007/BF01655185

No abstract available

PubMed Disclaimer

Similar articles

A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
Tormey DC, Weinberg VE, Holland JF, Weiss RB, Glidewell OJ, Perloff M, Falkson G, Falkson HC, Henry PH, Leone LA, et al. Tormey DC, et al. J Clin Oncol. 1983 Feb;1(2):138-45. doi: 10.1200/JCO.1983.1.2.138. J Clin Oncol. 1983. PMID: 6366133 Clinical Trial.
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S. Rivkin SE, et al. Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982. Cancer. 2003. PMID: 12491501 Clinical Trial.
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L; Cancer and Leukemia Group B. Weiss RB, et al. J Clin Oncol. 2003 May 1;21(9):1825-35. doi: 10.1200/JCO.2003.09.006. J Clin Oncol. 2003. PMID: 12721260 Clinical Trial.
Adjuvant therapy in primary breast cancer.
Wolmark N, Fisher B. Wolmark N, et al. Surg Clin North Am. 1985 Feb;65(1):161-80. doi: 10.1016/s0039-6109(16)43540-1. Surg Clin North Am. 1985. PMID: 3887616 Review.
Adjuvant therapy in breast cancer.
Dorr A. Dorr A. Curr Opin Oncol. 1990 Dec;2(6):1049-52. doi: 10.1097/00001622-199012000-00007. Curr Opin Oncol. 1990. PMID: 2099836 Review. No abstract available.

See all similar articles

Cited by

Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.
Shih YT, Dong W, Xu Y, Etzioni R, Shen Y. Shih YT, et al. Ann Intern Med. 2021 May;174(5):602-612. doi: 10.7326/M20-2912. Epub 2021 Feb 9. Ann Intern Med. 2021. PMID: 33556275 Free PMC article.
Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Ahern CH, Shen Y. Ahern CH, et al. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):718-25. doi: 10.1158/1055-9965.EPI-08-0918. Epub 2009 Mar 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19258473 Free PMC article.
Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.
Ahern CH, Shih YC, Dong W, Parmigiani G, Shen Y. Ahern CH, et al. Br J Cancer. 2014 Oct 14;111(8):1542-51. doi: 10.1038/bjc.2014.458. Epub 2014 Aug 19. Br J Cancer. 2014. PMID: 25137022 Free PMC article.

References

1. J Clin Oncol. 1983 Feb;1(2):138-45 - PubMed
1. Lancet. 1984 Aug 11;2(8398):307-11 - PubMed
1. Breast Cancer Res Treat. 1983;3 Suppl:S19-26 - PubMed
1. J Clin Oncol. 1985 Feb;3(2):259-75 - PubMed
1. Cancer. 1979 Sep;44(3):793-8 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information